loading page

Treatable Ataxia: a comprehensive case series study
  • +10
  • Mahmood reza Ashrafi,
  • Elham Pourbakhtyaran,
  • Mohammad Rohani,
  • Bita Shalbafan,
  • Ali Reza Tavasoli,
  • Sareh Hosseinpour ,
  • Maryam Rasulinezhad ,
  • Zahra Rezaei,
  • Ali Zare Dehnavi ,
  • Seyyed Mohammad Mahdi Hosseiny ,
  • Roya Haghighi,
  • Homa Ghabeli,
  • Morteza Heidari
Mahmood reza Ashrafi
Tehran University of Medical Sciences

Corresponding Author:ashrafim@tums.ac.ir

Author Profile
Elham Pourbakhtyaran
Tehran University of Medical Sciences
Author Profile
Mohammad Rohani
Iran University of Medical Sciences
Author Profile
Bita Shalbafan
Shahid Beheshti University of Medical Sciences
Author Profile
Ali Reza Tavasoli
Tehran University of Medical Sciences
Author Profile
Sareh Hosseinpour
Tehran University of Medical Sciences
Author Profile
Maryam Rasulinezhad
Tehran University of Medical Sciences
Author Profile
Zahra Rezaei
Tehran University of Medical Sciences
Author Profile
Ali Zare Dehnavi
Tehran University of Medical Sciences
Author Profile
Seyyed Mohammad Mahdi Hosseiny
Tehran University of Medical Sciences
Author Profile
Roya Haghighi
Tehran University of Medical Sciences
Author Profile
Homa Ghabeli
Tehran University of Medical Sciences
Author Profile
Morteza Heidari
Tehran University of Medical Sciences
Author Profile

Abstract

Autosomal recessive cerebellar ataxias are a group of heterogeneous early-onset progressive disorders that some of them are treatable. We performed 4-year-follow up for 25 patients that considered as treatable ataxia in the literature. According to our study, patients would benefit from early detection of treatable ataxia, close observation, and follow-up.
04 Nov 2021Submitted to Clinical Case Reports
18 Nov 2021Submission Checks Completed
18 Nov 2021Assigned to Editor
08 Dec 2021Reviewer(s) Assigned
13 Feb 2022Review(s) Completed, Editorial Evaluation Pending
23 Feb 2022Editorial Decision: Revise Minor
01 Mar 20221st Revision Received
02 Mar 2022Submission Checks Completed
02 Mar 2022Assigned to Editor
02 Mar 2022Review(s) Completed, Editorial Evaluation Pending
28 Mar 2022Editorial Decision: Accept